Hara N - Search Results

1

The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.

Kawasaki M, Nakanishi Y, Kuwano K, Yatsunami J, Takayama K, Hara N. Kawasaki M, et al. Among authors: hara n. Clin Cancer Res. 1997 Jul;3(7):1195-200. Clin Cancer Res. 1997. PMID: 9815799

2

[Small cell lung cancer associated with ectopic ACTH syndrome].

Takano K, Takayama K, Nakano H, Hagimoto N, Nakanishi Y, Hara N. Takano K, et al. Among authors: hara n. Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Feb;34(2):220-5. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 8622281 Japanese.

3

Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.

Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N. Bai F, et al. Among authors: hara n. Cancer. 1996 Aug 1;78(3):416-21. doi: 10.1002/(SICI)1097-0142(19960801)78:3<416::AID-CNCR6>3.0.CO;2-H. Cancer. 1996. PMID: 8697385

4

Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.

Pei XH, Nakanishi Y, Takayama K, Bai F, Kawasaki M, Tsuruta N, Mizuno K, Hara N. Pei XH, et al. Among authors: hara n. Anticancer Drugs. 1997 Mar;8(3):231-7. doi: 10.1097/00001813-199703000-00003. Anticancer Drugs. 1997. PMID: 9095327

5

Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.

Takayama K, Ogata K, Nakanishi Y, Yatsunami J, Kawasaki M, Hara N. Takayama K, et al. Among authors: hara n. Cancer J Sci Am. 1996 Jul-Aug;2(4):212-6. Cancer J Sci Am. 1996. PMID: 9166534

6

P53 immunostaining predicts chemosensitivity in non-small cell lung cancer: A preliminary report.

Kawasaki M, Nakanishi Y, Yatsunami J, Takayama K, Ochiai S, Xinhai P, Kuwano K, Hara N. Kawasaki M, et al. Among authors: hara n. Cancer J Sci Am. 1996 Jul-Aug;2(4):217-20. Cancer J Sci Am. 1996. PMID: 9166535

7

Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.

Nakanishi Y, Takayama K, Kawasaki M, Yatsunami J, Inutsuka S, Wakamatsu K, Tsuruta N, Hara N. Nakanishi Y, et al. Among authors: hara n. Am J Clin Oncol. 1997 Aug;20(4):393-7. doi: 10.1097/00000421-199708000-00015. Am J Clin Oncol. 1997. PMID: 9256897 Clinical Trial.

8

Detection of group C adenovirus DNA in small-cell lung cancer with the nested polymerase chain reaction.

Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Nomoto Y, Matsuba T, Nakanishi Y, Hara N. Kuwano K, et al. Among authors: hara n. J Cancer Res Clin Oncol. 1997;123(7):377-82. doi: 10.1007/BF01240120. J Cancer Res Clin Oncol. 1997. PMID: 9260589

9

[Expression of CD44 standard and CD44 variant 6 in human lung cancer].

Ochiai S, Nakanishi Y, Mizuno K, Hashimoto S, Inutsuka S, Kawasaki M, Yatsunami J, Hara N. Ochiai S, et al. Among authors: hara n. Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Nov;35(11):1179-85. Nihon Kyobu Shikkan Gakkai Zasshi. 1997. PMID: 9493443 Japanese.

10

Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung.

Yatsunami J, Tsuruta N, Ogata K, Wakamatsu K, Takayama K, Kawasaki M, Nakanishi Y, Hara N, Hayashi S. Yatsunami J, et al. Among authors: hara n. Cancer Lett. 1997 Nov 25;120(1):101-8. doi: 10.1016/s0304-3835(97)00296-6. Cancer Lett. 1997. PMID: 9570392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,112 results

Search Page

Filters